Answers are grounded in this paper and cite their sources.
Two recent studies have highlighted the potential of nasal microbiota transplantation (NMT) to treat chronic rhinosinusitis (CRS). Here we evaluate these findings and propose that lessons from fecal microbiota transplantation (FMT) could guide NMT development, with possible implications for combating antimicrobial resistance in respiratory infections.
No takes yet. Share an insight, caveat, or question.
Shekhar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: